An incredible year for Creavo with exciting prospects for 2019

An incredible year for Creavo with exciting prospects for 2019

By Steve Parker, Chief Executive Officer It’s been an incredible year for Creavo, as we move ever closer to the commercialisation of Corsens®, the world’s first deployable MCG device with the potential to revolutionise the cardiac triage process, it is more important...
Creavo launches largest US study of its kind

Creavo launches largest US study of its kind

A new cardiac diagnostic device aimed at helping physicians rule out active ischaemia in patients presenting to the emergency department (ED) with chest pain is being trialled at five of the most respected research facilities in the United States (Mayo Clinic,...